加强
医学
耐火材料(行星科学)
白血病
癌症研究
肿瘤科
内科学
生物
哲学
语言学
天体生物学
作者
Ghayas C. Issa,Ibrahim Aldoss,Michael J. Thirman,John F. DiPersio,Martha Arellano,James S. Blachly,Gabriel N. Mannis,Alexander E. Perl,David S. Dickens,Christine M. McMahon,Elie Traer,C. Michel Zwaan,Carolyn Grove,Richard M. Stone,Paul J. Shami,Ioannis Mantzaris,Matthew Greenwood,Neerav Shukla,Branko Cuglievan,Tibor Kovacsovics
摘要
Revumenib, an oral, small molecule inhibitor of the menin-lysine methyltransferase 2A (KMT2A) interaction, showed promising efficacy and safety in a phase I study of heavily pretreated patients with
科研通智能强力驱动
Strongly Powered by AbleSci AI